RECONCILIATION OF SHARE CAPITAL AUDIT | |||
| Scrip code* | 540879 | ||
| NSE Symbol | APOLLO | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE713T01028 | ||
| Whether company has CIN | Yes | ||
| CIN Number | L72200TG1997PLC026556 | ||
| Name of the company* | APOLLO MICRO SYSTEMS LIMITED | ||
| Registered office address | |||
| Registered office address* | Plot No 128/A, Road No 12, BEL Road IDA Mallapur,Uppal Mandal Hyderabad- 500 076 | ||
| Registered office state* | TELANGANA | ||
| Registered office city* | HYDERABAD | ||
| Registered office district* | HYDERABAD | ||
| Registered office pin code* | 500076 | ||
| Registered office contact number* | ISD Code* | STD Code* | Number* |
| 91 | 040 | 27167000 | |
| Registered office fax | 040 | 27150820 | |
| Registered office country* | INDIA | ||
| Registered office website | www.apollo-micro.com | ||
| Registered office email | cs@apollo-micro.com | ||
| Correspondence address | |||
| Same as above | Yes | ||
| Correspondence address | Plot No 128/A, Road No 12, BEL Road IDA Mallapur,Uppal Mandal Hyderabad- 500 076 | ||
| Correspondence state | TELANGANA | ||
| Correspondence city | HYDERABAD | ||
| Correspondence district | HYDERABAD | ||
| Correspondence pin code | 500076 | ||
| Correspondence contact number | ISD Code | STD Code | Number |
| 91 | 040 | 27167000 | |
| Correspondence fax | 040 | 27150820 | |
| Correspondence country | INDIA | ||
| Correspondence email | cs@apollo-micro.com | ||
| Reporting quarter* | 30-06-2023 | ||
| Face value* | 1 | ||
Stock Exchange Details : | Name of stock Exchange | Listed Capital | % Of total issued capital |
| Name of other stock exchanges where the company's securities are listed | BSE Ltd | 207638860 | 90.03 |
| National Stock Exchange of India Ltd(NSE) | 207638860 | 90.03 | |
| Remarks | Textual Information(1) |
Text Block | |||||||||||||||||||||||
| Textual Information(1) | NOTE:
The company had allotted 98,85,070 convertible warrants, on preferential basis to promoters and non promoters with an option to convert the same into equal number of equity shares at a price of Rs.186/- per warrant, including premium of Rs. 176/- per share on face value of Rs.10/- per share, within a period of 18 months from the date of allotment of warrants i.e.5th December, 2022, as per terms and conditions approved in EGM held on 12th November, 2022. The Company had also received in-principle approval from the BSE Limited and National Stock Exchange of India Limited on 22nd November 2022 for this matter. Subsequently, the company had sub divided (stock split) equity share from face value of Rs.10/- to Rs. 1/- per share, pursuant to the share holders approval for Sub - division of every 1 (One) equity share of face value of Rs 10/- (Rupees Ten only) each into 10 (Ten) equity shares of the face value of Re 1/- (Rupee One only) each, with effect from the record date Thursday, 4th May 2023. Hence, after considering stock split effects into number and price of warrant, the total 98,85,070 warrants outstanding for conversion into equity share of Re. 1/- each.
Out the allotted warrants, the Securities Allotment Committee of the Board of Directors of the Company on has allotted 2,29,99,990 equity shares (49,99,990 equity shares on 23rd May 2023 and 1,80,00,000 Equity Shares of face value of Re. 1/- each on 29th May 2023) to the warrant holders who exercised the warrants.
For the above allotted Equity shares, the Company has received the National Stock Exchange of India Limited Listing approval on 28th June 2023 and the BSE Limited Listing approval on 4th July 2023.
The Company has executed Corporate Action with NSDL and CDSL and the credit confirmation from the Depositories received on 14th July 2023. The Company has applied and received the Trading approval for the above mentioned equity shares on 20th July 2023.
In the view of the above, there will be following difference:
- 2,29,99,990 equity shares for the Listed Capital among National Stock Exchange of India Limited and the BSE Limited as the Listing Approval of National Stock Exchange of India Limited received on 28th June 2023 and the BSE Limited on 4th July 2023. - 2,29,99,990 equity shares among Issued Capital and Listed Capital as the we have received the Listing approvals on different dates from among National Stock Exchange of India Limited and the BSE Limited as stated above. - 2,29,99,990 equity shares among Issued Capital and Total Number of Shares as the we have received the Listing approvals on different dates from among National Stock Exchange of India Limited and the BSE Limited as stated above. - 2,29,99,990 equity shares among Listed Capital and Total Number of Shares as the we have received the Listing approvals on different dates from among National Stock Exchange of India Limited and the BSE Limited as stated above.
Therefore, as on Quarter ended 30th June 2023, the issued, paid up and Listed capital of the Company exchange wise is as follows:
| ||||||||||||||||||||||
Capital Details : | ||
| Number of shares | % Of total issued capital | |
| Issued capital* | 230638850 | |
| Listed capital (BSE) (As per company records)* | 207638860 | 90.03 |
| Held in dematerialised form in CDSL* | 40024944 | 17.35 |
| Held in dematerialised form in NSDL* | 167613836 | 72.67 |
| Physical* | 80 | 0 |
| Total no.of shares* | 207638860 | 90 |
| Reasons for difference if any, Between issued capital and listed capital* | 22999990 | Textual Information(1) |
| Reasons for difference if any, Between issued capital and total number of shares* | 22999990 | Textual Information(2) |
| Reasons for difference if any, Between listed capital and total number of shares* | 0 | |
Text Block | |
| Textual Information(1) | NOTE:
1. The company allotted 98,85,070 convertible warrants, on preferential basis to promoters and non- promoters with an option to convert the same into equal number of equity shares at a price of Rs.186/- per warrant, including premium of Rs. 176/- per share on face value of Rs.10/- per share, within a period of 18 months from the date of allotment of warrants i.e. 5th December, 2022, as per terms and conditions approved in EGM held on 12th November, 2022. The Company received in-principle approval from BSE Limited and National Stock Exchange of India Limited on 22nd November 2022 for this matter. Subsequently, the company had sub divided (stock split) equity share from face value of Rs.10/- to Rs. 1/- per share, pursuant to the share holders approval for Sub - division of every 1 (One) equity share of face value of Rs 10/- (Rupees Ten only) each into 10 (Ten) equity shares of the face value of Re 1/- (Rupee One only) each, with effect from the record date ie., 4th May 2023. Hence, after considering stock split effects into number and price of warrant, a total of 98,85,070warrants were outstanding for conversion of each warrant into 10 Equity Shares of Re 1/- each.
Out of the allotted warrants, the Securities Allotment Committee of the Board of Directors of the Company allotted 2,29,99,990 equity shares (i.e., 49,99,990 equity shares on 23rd May 2023 and 1,80,00,000 Equity Shareson 29th May 2023 of face value of Re. 1/- each) to the warrant holders who exercised the warrants.
For the above allotted Equity shares, the Company received Listing approval from NationalStock Exchange of India Limited on 28th June 2023 and from BSE Limited on 4th July 2023. Post receipt of Listing approvals, the Company initiated Corporate Action with NSDL and CDSL and credit confirmation from the Depositories was received on 14th July 2023. The Company applied and received Trading approval for the above mentioned equity shares on 20th July 2023. Therefore, as on Quarter ended 30/06/2023, the issued and paid up capital of the Company isRs 23,06,38,850/- consisting of 23,06,38,850 equity shares of Re. 1/- each and Listed Capital on NSE and BSE Limited is Rs. 20,76,38,860 consisting of 20,76,38,860 equity shares of Re. 1/- each |
| Textual Information(2) | NOTE:
1. The company allotted 98,85,070 convertible warrants, on preferential basis to promoters and non- promoters with an option to convert the same into equal number of equity shares at a price of Rs.186/- per warrant, including premium of Rs. 176/- per share on face value of Rs.10/- per share, within a period of 18 months from the date of allotment of warrants i.e. 5th December, 2022, as per terms and conditions approved in EGM held on 12th November, 2022. The Company received in-principle approval from BSE Limited and National Stock Exchange of India Limited on 22nd November 2022 for this matter. Subsequently, the company had sub divided (stock split) equity share from face value of Rs.10/- to Rs. 1/- per share, pursuant to the share holders approval for Sub - division of every 1 (One) equity share of face value of Rs 10/- (Rupees Ten only) each into 10 (Ten) equity shares of the face value of Re 1/- (Rupee One only) each, with effect from the record date ie., 4th May 2023. Hence, after considering stock split effects into number and price of warrant, a total of 98,85,070warrants were outstanding for conversion of each warrant into 10 Equity Shares of Re 1/- each.
Out of the allotted warrants, the Securities Allotment Committee of the Board of Directors of the Company allotted 2,29,99,990 equity shares (i.e., 49,99,990 equity shares on 23rd May 2023 and 1,80,00,000 Equity Shareson 29th May 2023 of face value of Re. 1/- each) to the warrant holders who exercised the warrants.
For the above allotted Equity shares, the Company received Listing approval from NationalStock Exchange of India Limited on 28th June 2023 and from BSE Limited on 4th July 2023. Post receipt of Listing approvals, the Company initiated Corporate Action with NSDL and CDSL and credit confirmation from the Depositories was received on 14th July 2023. The Company applied and received Trading approval for the above mentioned equity shares on 20th July 2023. Therefore, as on Quarter ended 30/06/2023, the issued and paid up capital of the Company isRs 23,06,38,850/- consisting of 23,06,38,850 equity shares of Re. 1/- each and Listed Capital on NSE and BSE Limited is Rs. 20,76,38,860 consisting of 20,76,38,860 equity shares of Re. 1/- each |
Certifying the details of changes in share capital during the quarter under consideration as per Table below : | |
| Whether changes during the quarter* | Yes |
Certifying the details of changes in share capital during the quarter under consideration as per Table below : | ||||||||
| Serial No. | Particulars | No.of shares | Applied / Not Applied for listing | Listed on Stock Exchanges (Specify Names) | whether intimated to CDSL | whether intimated to NSDL | In-prin appr. pending for SE (Specify Names) | Remarks |
| 1 | Preferential Issue | 22999990 | Applied | BSE Ltd | No | No | Yes | Textual Information(1) |
| 2 | Preferential Issue | 22999990 | Applied | National Stock Exchange of India Ltd(NSE) | No | No | Yes | Textual Information(2) |
Text Block | |
| Textual Information(1) | NOTE:
1. The company allotted 98,85,070 convertible warrants, on preferential basis to promoters and non- promoters with an option to convert the same into equal number of equity shares at a price of Rs.186/- per warrant, including premium of Rs. 176/- per share on face value of Rs.10/- per share, within a period of 18 months from the date of allotment of warrants i.e. 5th December, 2022, as per terms and conditions approved in EGM held on 12th November, 2022. The Company received in-principle approval from BSE Limited and National Stock Exchange of India Limited on 22nd November 2022 for this matter. Subsequently, the company had sub divided (stock split) equity share from face value of Rs.10/- to Rs. 1/- per share, pursuant to the share holders approval for Sub - division of every 1 (One) equity share of face value of Rs 10/- (Rupees Ten only) each into 10 (Ten) equity shares of the face value of Re 1/- (Rupee One only) each, with effect from the record date ie., 4th May 2023. Hence, after considering stock split effects into number and price of warrant, a total of 98,85,070warrants were outstanding for conversion of each warrant into 10 Equity Shares of Re 1/- each.
Out of the allotted warrants, the Securities Allotment Committee of the Board of Directors of the Company allotted 2,29,99,990 equity shares (i.e., 49,99,990 equity shares on 23rd May 2023 and 1,80,00,000 Equity Shareson 29th May 2023 of face value of Re. 1/- each) to the warrant holders who exercised the warrants.
For the above allotted Equity shares, the Company received Listing approval from NationalStock Exchange of India Limited on 28th June 2023 and from BSE Limited on 4th July 2023. Post receipt of Listing approvals, the Company initiated Corporate Action with NSDL and CDSL and credit confirmation from the Depositories was received on 14th July 2023. The Company applied and received Trading approval for the above mentioned equity shares on 20th July 2023. Therefore, as on Quarter ended 30/06/2023, the issued and paid up capital of the Company isRs 23,06,38,850/- consisting of 23,06,38,850 equity shares of Re. 1/- each and Listed Capital on NSE and BSE Limited is Rs. 20,76,38,860 consisting of 20,76,38,860 equity shares of Re. 1/- each |
| Textual Information(2) | NOTE:
1. The company allotted 98,85,070 convertible warrants, on preferential basis to promoters and non- promoters with an option to convert the same into equal number of equity shares at a price of Rs.186/- per warrant, including premium of Rs. 176/- per share on face value of Rs.10/- per share, within a period of 18 months from the date of allotment of warrants i.e. 5th December, 2022, as per terms and conditions approved in EGM held on 12th November, 2022. The Company received in-principle approval from BSE Limited and National Stock Exchange of India Limited on 22nd November 2022 for this matter. Subsequently, the company had sub divided (stock split) equity share from face value of Rs.10/- to Rs. 1/- per share, pursuant to the share holders approval for Sub - division of every 1 (One) equity share of face value of Rs 10/- (Rupees Ten only) each into 10 (Ten) equity shares of the face value of Re 1/- (Rupee One only) each, with effect from the record date ie., 4th May 2023. Hence, after considering stock split effects into number and price of warrant, a total of 98,85,070warrants were outstanding for conversion of each warrant into 10 Equity Shares of Re 1/- each.
Out of the allotted warrants, the Securities Allotment Committee of the Board of Directors of the Company allotted 2,29,99,990 equity shares (i.e., 49,99,990 equity shares on 23rd May 2023 and 1,80,00,000 Equity Shareson 29th May 2023 of face value of Re. 1/- each) to the warrant holders who exercised the warrants.
For the above allotted Equity shares, the Company received Listing approval from NationalStock Exchange of India Limited on 28th June 2023 and from BSE Limited on 4th July 2023. Post receipt of Listing approvals, the Company initiated Corporate Action with NSDL and CDSL and credit confirmation from the Depositories was received on 14th July 2023. The Company applied and received Trading approval for the above mentioned equity shares on 20th July 2023. Therefore, as on Quarter ended 30/06/2023, the issued and paid up capital of the Company isRs 23,06,38,850/- consisting of 23,06,38,850 equity shares of Re. 1/- each and Listed Capital on NSE and BSE Limited is Rs. 20,76,38,860 consisting of 20,76,38,860 equity shares of Re. 1/- each |
| Register of members is updated* | Yes |
| If not, Updated upto which date | |
| Reference of previous quarter with regards to excess dematerialised shares,If any. | |
| Has the company resolved the matter (excess dematerialised shares mentioned above) in the current quarter ?* | NA |
| If not, Reason why ? |
Mentioned the total no.of requests, If any, confirmed after 21 days and the total no.of requests pending beyond 21 days with the reasons for delay | |||
| Total no.of demat requests | No.of requests* | No.of shares* | Reasons for delay |
| Confirmed after 21 days* | 0 | 0 | |
| Pending for more than 21 days* | 0 | 0 | |
| Remarks | |||
Compliance Officer Details | ||
| Whether Compliance officer appointed | Yes | |
| Whether Qualified Company Secretary is Compliance Officer * | No | |
| Name of the compliance officer* | SUDARSHAN CHILUVERU | |
| PAN of the compliance officer* | AASPC7991A | |
| Date of Appointment | 31-05-2023 | |
| Designation* | chief financial officer and compliance officer | |
| Membership Nos | ||
| Mobile no.* | 9490422594 | |
| Fax no. | ||
| E-mail id* | cs@apollo-micro.com | |
| Whether any change in Compliance Officer during the previous 2 quarters* | Yes | |
| Whether the previous Compliance Officer was Qualified Company Secretary * | Yes | |
Whether the previous Compliance Officer was Qualified Company Secretary * | ||
| Previous Compliance Officer Name | VITTA CHAITANYA SIVA SHANKAR | |
| PAN of the previous compliance officer* | CCOPS8380M | |
| Membership Nos | FCS | 12587 |
| Date of Appointment | 01-02-2017 | |
| Date of Cessation | 31-05-2023 | |
Date of Appointment | |
| CA/CS/CMA* | Company secretary |
| Name of certifying auditor* | Sridevi Madati |
| Date of issue of report* | 27-07-2023 |
| Address* | H. No. 20-3/2/A, Gautamnagar, Malkajgiri, Hyderabad-500047 |
| City* | Hyderabad |
| Pincode* | 500047 |
| Contact no.* | 040-9885040075 |
| Fax no. | - |
| mnmadnassociates@gmail.com | |
| Membership no.* | 6476 |
| Firms registration number of audit firm | |
| Name of the firm* | MNM & Associates |
| COP number* | 11694 |
Name of the firm* | |
| Appointment of common agency for share registry work* | Yes |
| Whether Registered with SEBI | |
| Name of RTA | BIGSHARE SERVICES PRIVATE LIMITED |
| SEBI registration no. | INR000001385 |
| Address | Office No S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai – 400093. |
| State | Maharashtra |
| City | Mumbai |
| Pincode | 400093 |
| Contact no. | 022-62638200 |
| Fax number of RTA | 022-62638299 |
| E-mail id | marketing@bigshareonline.com |
| Website Address | www.bigshareonline.com |
| Whether any change in Registrar and Share Transfer Agents * | No |
| Previous Registrar and Share Transfer Agents Name | |
| Date of Cessation | |
| Any other detail that the auditor may like to provide. (e.g. BIFR company, delisting from SE) | |